Impaired cell fate through gain-of-function mutations in a chromatin reader

被引:100
|
作者
Wan, Liling [1 ,16 ]
Chong, Shasha [2 ,3 ]
Xuan, Fan [4 ]
Liang, Angela [1 ]
Cui, Xiaodong [5 ,6 ]
Gates, Leah [1 ]
Carroll, Thomas S. [7 ]
Li, Yuanyuan [8 ]
Feng, Lijuan [1 ]
Chen, Guochao [8 ]
Wang, Shu-Ping [9 ,10 ]
Ortiz, Michael V. [11 ]
Daley, Sara K. [12 ]
Wang, Xiaolu [4 ]
Xuan, Hongwen [4 ]
Kentsis, Alex [11 ,13 ]
Muir, Tom W. [12 ]
Roeder, Robert G. [9 ]
Li, Haitao [8 ]
Li, Wei [5 ,6 ,14 ]
Tjian, Robert [2 ,3 ,15 ]
Wen, Hong [4 ]
Allis, C. David [1 ]
机构
[1] Rockefeller Univ, Lab Chromatin Biol & Epigenet, 1230 York Ave, New York, NY 10021 USA
[2] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA
[3] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA
[4] Van Andel Inst, Ctr Epigenet, Grand Rapids, MI 49546 USA
[5] Baylor Coll Med, Div Biostat, Dan L Duncan Canc Ctr, Houston, TX 77030 USA
[6] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
[7] Rockefeller Univ, Bioinformat Core, 1230 York Ave, New York, NY 10021 USA
[8] Tsinghua Univ, Sch Med, Dept Basic Med Sci, Beijing Adv Innovat Ctr Struct Biol,MOE Key Lab P, Beijing, Peoples R China
[9] Rockefeller Univ, Lab Biochem & Mol Biol, 1230 York Ave, New York, NY 10021 USA
[10] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan
[11] Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA
[12] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA
[13] Mem Sloan Kettering Canc Ctr, Mol Pharmacol Program, Sloan Kettering Inst, 1275 York Ave, New York, NY 10021 USA
[14] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA
[15] Univ Calif Berkeley, CIRM Ctr Excellence, Berkeley, CA 94720 USA
[16] Univ Penn, Dept Canc Biol, Perelman Sch Med, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
TRANSCRIPTION; ELONGATION; COMPLEX; ENL; TEFB; AFF4;
D O I
10.1038/s41586-019-1842-7
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Modifications of histone proteins have essential roles in normal development and human disease. Recognition of modified histones by 'reader' proteins is a key mechanism that mediates the function of histone modifications, but how the dysregulation of these readers might contribute to disease remains poorly understood. We previously identified the ENL protein as a reader of histone acetylation via its YEATS domain, linking it to the expression of cancer-driving genes in acute leukaemia1. Recurrent hotspot mutations have been found in the ENL YEATS domain in Wilms tumour2,3, the most common type of paediatric kidney cancer. Here we show, using human and mouse cells, that these mutations impair cell-fate regulation by conferring gain-of-function in chromatin recruitment and transcriptional control. ENL mutants induce gene-expression changes that favour a premalignant cell fate, and, in an assay for nephrogenesis using murine cells, result in undifferentiated structures resembling those observed in human Wilms tumour. Mechanistically, although bound to largely similar genomic loci as the wild-type protein, ENL mutants exhibit increased occupancy at a subset of targets, leading to a marked increase in the recruitment and activity of transcription elongation machinery that enforces active transcription from target loci. Furthermore, ectopically expressed ENL mutants exhibit greater self-association and form discrete and dynamic nuclear puncta that are characteristic of biomolecular hubs consisting of local high concentrations of regulatory factors. Such mutation-driven ENL self-association is functionally linked to enhanced chromatin occupancy and gene activation. Collectively, our findings show that hotspot mutations in a chromatinreader domain drive self-reinforced recruitment, derailing normal cell-fate control during development and leading to an oncogenic outcome.
引用
收藏
页码:121 / +
页数:18
相关论文
共 50 条
  • [1] Impaired cell fate through gain-of-function mutations in a chromatin reader
    Liling Wan
    Shasha Chong
    Fan Xuan
    Angela Liang
    Xiaodong Cui
    Leah Gates
    Thomas S. Carroll
    Yuanyuan Li
    Lijuan Feng
    Guochao Chen
    Shu-Ping Wang
    Michael V. Ortiz
    Sara K. Daley
    Xiaolu Wang
    Hongwen Xuan
    Alex Kentsis
    Tom W. Muir
    Robert G. Roeder
    Haitao Li
    Wei Li
    Robert Tjian
    Hong Wen
    C. David Allis
    Nature, 2020, 577 : 121 - 126
  • [2] Analysis of sperm galactosyltransferase through gain-of-function and loss-of-function mutations
    Shur, B
    Lu, QX
    Shi, XD
    Paruchuru, K
    Miller, D
    MOLECULAR BIOLOGY OF THE CELL, 1998, 9 : 7A - 7A
  • [3] Drosophila Lyra mutations are gain-of-function mutations of senseless
    Nolo, R
    Abbott, LA
    Bellen, HJ
    GENETICS, 2001, 157 (01) : 307 - 315
  • [4] In vitro selection of fibronectin gain-of-function mutations
    Tani, PH
    Loftus, JC
    Bowditch, RD
    BIOCHEMICAL JOURNAL, 2002, 365 (365) : 287 - 294
  • [5] GAIN-OF-FUNCTION LETHAL MUTATIONS IN THE RECA GENE
    CAMPBELL, M
    DAVIS, R
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 101 - 101
  • [6] Seizure suppression by gain-of-function escargot mutations
    Hekmat-Scafe, DS
    Dang, KN
    Tanouye, MA
    GENETICS, 2005, 169 (03) : 1477 - 1493
  • [7] Gain-of-function STING mutations induce T cell death in the SAVI mouse
    Wu, Jianjun
    Yan, Nan
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [8] Gain-of-Function Mutations: An Emerging Advantage for Cancer Biology
    Li, Yongsheng
    Zhang, Yunpeng
    Li, Xia
    Yi, Song
    Xu, Juan
    TRENDS IN BIOCHEMICAL SCIENCES, 2019, 44 (08) : 659 - 674
  • [9] Prions may act as the gain-of-function mutations.
    Nizhnikov, A. A.
    Antonets, K. S.
    Kliver, S. F.
    Polev, D. E.
    Shuvalova, A. R.
    Andreeva, E. A.
    Inge-Vechtomov, S. G.
    MOLECULAR BIOLOGY OF THE CELL, 2017, 28
  • [10] INF2 mutations cause kidney disease through a gain-of-function mechanism
    Subramanian, Balajikarthick
    Williams, Sarah
    Karp, Sophie
    Hennino, Marie-Flore
    Jacas, Sonako
    Lee, Miriam
    Riella, Cristian V.
    Alper, Seth L.
    Higgs, Henry N.
    Pollak, Martin R.
    SCIENCE ADVANCES, 2024, 10 (46):